MX2012011938A - Compuesto para tratamiento de condicion o enfermedad respiratoria. - Google Patents
Compuesto para tratamiento de condicion o enfermedad respiratoria.Info
- Publication number
- MX2012011938A MX2012011938A MX2012011938A MX2012011938A MX2012011938A MX 2012011938 A MX2012011938 A MX 2012011938A MX 2012011938 A MX2012011938 A MX 2012011938A MX 2012011938 A MX2012011938 A MX 2012011938A MX 2012011938 A MX2012011938 A MX 2012011938A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- disease
- compound
- respiratory condition
- exacerbations
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 230000004199 lung function Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010901601A AU2010901601A0 (en) | 2010-04-15 | Compound for the treatment of respiratory condition or disease | |
| PCT/AU2011/000434 WO2011127538A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012011938A true MX2012011938A (es) | 2013-01-28 |
Family
ID=44788654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012011938A MX2012011938A (es) | 2010-04-15 | 2011-04-14 | Compuesto para tratamiento de condicion o enfermedad respiratoria. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110257192A1 (enExample) |
| EP (1) | EP2558097B1 (enExample) |
| JP (1) | JP6148618B2 (enExample) |
| KR (1) | KR20130106267A (enExample) |
| CN (2) | CN105560245A (enExample) |
| AU (1) | AU2011241478B2 (enExample) |
| BR (1) | BR112012026244A2 (enExample) |
| CA (1) | CA2796207A1 (enExample) |
| EA (1) | EA025224B1 (enExample) |
| ES (1) | ES2647223T3 (enExample) |
| IL (1) | IL222244A0 (enExample) |
| MX (1) | MX2012011938A (enExample) |
| NZ (1) | NZ603040A (enExample) |
| SG (2) | SG184430A1 (enExample) |
| WO (1) | WO2011127538A1 (enExample) |
| ZA (1) | ZA201207696B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2909057C (en) | 2013-04-12 | 2022-03-22 | Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises" | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| BR112016029942A2 (pt) | 2014-06-20 | 2017-08-22 | Aviragen Therapeutics Inc | composto, forma de base livre cristalina anidra, composição farmacêutica, método para fabricação de uma forma de base livre cristalina, método de tratamento de uma infecção viral, método de tratar, aliviar, prevenir ou reduzir os sintomas ou exacerbações de asma ou doença pulmonar obstrutiva crônica e método de tratamento de doença mão, pé e boca |
| WO2024192151A2 (en) * | 2023-03-13 | 2024-09-19 | Altesa BioSciences, Inc. | Method of dosing vapendavir to treat enterovirus infections |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| CA2475971A1 (en) * | 2002-02-14 | 2003-08-21 | Viropharma Incorporated | Methods of reducing rhinovirus contagion and related compositions |
| ATE399549T1 (de) * | 2003-02-21 | 2008-07-15 | Apodemus Ab | Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril |
| US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
| US20060069124A1 (en) * | 2004-09-07 | 2006-03-30 | Rao P S | Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases |
| AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| NZ590286A (en) * | 2008-05-27 | 2011-08-26 | Biota Scient Management | Phosphate and sulphate salts of 6-{ 2-[1-(6-methyl-3-pyrazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole |
| TW201016215A (en) * | 2008-07-17 | 2010-05-01 | Schering Corp | Compositions and uses of antiviral active pharmaceutical agents |
-
2011
- 2011-04-14 SG SG2012073565A patent/SG184430A1/en unknown
- 2011-04-14 BR BR112012026244A patent/BR112012026244A2/pt not_active IP Right Cessation
- 2011-04-14 WO PCT/AU2011/000434 patent/WO2011127538A1/en not_active Ceased
- 2011-04-14 MX MX2012011938A patent/MX2012011938A/es not_active Application Discontinuation
- 2011-04-14 CN CN201510982692.9A patent/CN105560245A/zh active Pending
- 2011-04-14 CN CN2011800192025A patent/CN102844032A/zh active Pending
- 2011-04-14 NZ NZ60304011A patent/NZ603040A/en not_active IP Right Cessation
- 2011-04-14 EP EP11768285.6A patent/EP2558097B1/en not_active Not-in-force
- 2011-04-14 SG SG10201502391WA patent/SG10201502391WA/en unknown
- 2011-04-14 CA CA2796207A patent/CA2796207A1/en not_active Abandoned
- 2011-04-14 EA EA201201416A patent/EA025224B1/ru not_active IP Right Cessation
- 2011-04-14 JP JP2013504064A patent/JP6148618B2/ja active Active
- 2011-04-14 KR KR1020127029232A patent/KR20130106267A/ko not_active Ceased
- 2011-04-14 AU AU2011241478A patent/AU2011241478B2/en not_active Ceased
- 2011-04-14 ES ES11768285.6T patent/ES2647223T3/es active Active
- 2011-04-15 US US13/087,624 patent/US20110257192A1/en not_active Abandoned
-
2012
- 2012-10-09 IL IL222244A patent/IL222244A0/en unknown
- 2012-10-12 ZA ZA2012/07696A patent/ZA201207696B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013523844A (ja) | 2013-06-17 |
| NZ603040A (en) | 2015-03-27 |
| WO2011127538A1 (en) | 2011-10-20 |
| AU2011241478B2 (en) | 2016-12-01 |
| EP2558097A4 (en) | 2013-09-11 |
| JP6148618B2 (ja) | 2017-06-14 |
| ES2647223T3 (es) | 2017-12-20 |
| CN105560245A (zh) | 2016-05-11 |
| EP2558097A1 (en) | 2013-02-20 |
| SG184430A1 (en) | 2012-11-29 |
| CA2796207A1 (en) | 2011-10-20 |
| ZA201207696B (en) | 2014-03-26 |
| US20110257192A1 (en) | 2011-10-20 |
| EA201201416A1 (ru) | 2013-03-29 |
| EP2558097B1 (en) | 2017-10-25 |
| IL222244A0 (en) | 2012-12-31 |
| EA025224B1 (ru) | 2016-12-30 |
| CN102844032A (zh) | 2012-12-26 |
| KR20130106267A (ko) | 2013-09-27 |
| BR112012026244A2 (pt) | 2016-07-12 |
| SG10201502391WA (en) | 2015-05-28 |
| AU2011241478A1 (en) | 2012-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012110770A3 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
| EA201190108A1 (ru) | Фармацевтическая композиция для ингаляции | |
| PH12015501108A1 (en) | Treatment of pulmonary disease | |
| JO3150B1 (ar) | مشتقات بيريدين و بيرازين لعلاج مرض cf | |
| CA2897464C (en) | Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide | |
| EA201690335A1 (ru) | Новые средства для уменьшения негативных последствий курения | |
| ZA201303960B (en) | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases | |
| HK1214159A1 (zh) | 含有PDE4抑制剂和PI3δ或双重PI3δ-γ激酶抑制剂的药物组合物 | |
| TW200708513A (en) | Novel crystalline forms of tiotropium bromide | |
| GB2468073A (en) | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations | |
| WO2006117300A3 (en) | Crystalline forms of tiotropium bromide | |
| WO2011021203A3 (en) | Desferrioxamine-metal complexes for the treatment of immune-related disorders | |
| UA100777C2 (ru) | Вдыхаемые частички, содержащие тиотропий | |
| EA201290374A1 (ru) | Аэрозольная композиция для copd | |
| WO2013098672A3 (en) | Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations | |
| EP2585067A4 (en) | COMPOUND FOR THE TREATMENT OF ENTEROVIRUS | |
| SG10201807318RA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| WO2009019598A3 (en) | Inhalation therapy for respiratory disorders | |
| MX2012011938A (es) | Compuesto para tratamiento de condicion o enfermedad respiratoria. | |
| WO2015023508A3 (en) | Methods for improving asthma symptoms using benralizumab | |
| MX2012002091A (es) | Uso de antibioticos en aerosol para el tratamiento de la enfermedad pulmonar obstructiva cronica. | |
| UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
| MX2016001539A (es) | Particulas inhalables que comprenden tiotropio e indacaterol. | |
| MX2010008685A (es) | Farmacoforos duales-antagonistas muscarinicos de pde4. | |
| BR112015004810A2 (pt) | preparações de tiotrópio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |